Strategic advice from experts you trust

Gilead Sciences

Welcome to the Weekly Gist, where we distill the latest healthcare news, trends and our conversations with industry leaders into actionable guidance for CEOs and senior executives.

For more insights like these, subscribe to the Weekly Gist and receive an executive-level analysis of the week’s news delivered your inbox every Friday.

The Weekly Gist: The Cats Versus Birds Edition

As the US enters a third wave of the pandemic, the FDA grants full approval of a COVID therapy for the first time. Meanwhile, a new survey suggests that Americans are growing more skeptical of a possible coronavirus vaccine.
Read More

The Weekly Gist: The Hitting the Century Mark Edition

Most states are reopening faster than federal guidelines dictate, as the economy worsens and virus casualties continue to mount. Meanwhile, a thriving health insurer promises rebates to its enrollees.
Read More

The Weekly Gist: The Quarantine Fatigue Edition

As the coronavirus death rate plateaus, new economic data show that healthcare drove huge losses in the US economy in the first quarter. Meanwhile, new hope is emerging for effective coronavirus treatment and a possible early vaccine.
Read More

The Weekly Gist: The Brave New World Edition

The White House unveils guidelines for state and local officials to use in loosening stay-at-home restrictions and reopening the economy. Meanwhile, concerns about the adequacy of coronavirus testing continued to mount.
Read More